维普中文期刊产品整合服务
12篇 您的检索式:作者名="Almadani"
    题名 作者 年代 出处 被引量
1Concurrent rib and pelvic fractures as an indicator of solid abdominal organ injury显示文摘Ammar Al-Hassani Ibrahim Afifi Husham Abdelrahman Ayman El-Menyar Ammar Almadani Jan Recicar Hassan Al-Thani Kimball Maull Rifat Latifi 2013International Journal of Surgery2013,,6:1
2Synergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute experiment toxoplasmosis显示文摘Derouin F Almadany R Chau F et al 1992Antimicrob Agents Chemother1992,,:1
3Generation of Liver Disease-Specific Induced Pluripotent Stem Cells Along with Efficient Differentiation to Functional Hepatocyte-Like Cells显示文摘Arefeh Ghodsizadeh Adeleh Taei Mehdi Totonchi Ali Seifinejad Hamid Gourabi Behshad Pournasr Nasser Aghdami Reza Malekzadeh Navid Almadani Ghasem Hosseini Salekdeh Hossein Baharvand 2010Stem Cell Reviews and Reports2010,,4:1
4Particle Swarm Optimization for Task Assignment Problem 显示文摘Salman A Ahmad I Almadani S 2002Microprocessors and Microsystems2002,26,8:1
5Synergistic activity of azit- hromyein and pyrimethamine or sulfadiazine in acute experimental toxoplasmosis显示文摘DEROUIN F ALMADANY R CHAU F 1992Antimicrob Agents Chemother1992,36,5:1
6Synergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute Experiment Toxoplasma显示文摘Derouin F Almadany R Chau F 1992Antimicrob Agents Chemother1992,36,:1
7Synergistic activity of az- ithromycin and pyrimethamine or sulfadiazine in acute experimental toxoplasmosis 显示文摘Derouin F Almadany R Chau F 1992Antimicrob Agents Chemother1992,36,5:1
8Can a stroke present withflexor spasms? A highly rare experience 显示文摘Malik YM Almadani AA Dar JA 2014Ger Med Sci2014,12,:1
9Synergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute Experiment Toxoplasma 显示文摘Derouin F Almadany R Chau F 1992Antimicrob Agents Chemother1992,36,5:1
10Synergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute experiment toxoplasma显示文摘Derouin F Almadany R Chau F 1992Antirnicrob Agents Chemother1992,36,5:1
11Influence of drivers' comprehension of posted signs on their safety related characteristics显示文摘ALMADANIAL H M N 2000Accident Analysis and Preven tion2000,32,4:1
12Comparison of pediatric ventriculoperitoneal shunt infections arising in antibiotic-impregnated and standard catheters:a multicenter observational study显示文摘Antibiotic-impregnated ventricular shunt catheters(AIVSCs)with 0.15%clindamycin and 0.054%rifampin are commonly used to prevent ventriculo-peritoneal(VP)shunt infections.Initially approved by the United States Food and Drug Administration in 2003(http://gffzz811f98da39b34f51sp09vqfv9pbbk6xo9.ffgz.tsg.suse.edu.cn/file/general/1561404015.pdf),they have antimicrobial activity documented for minimum 31 days(http://gffzz0cea724c9af2432dsp09vqfv9pbbk6xo9.ffgz.tsg.suse.edu.cn/cdrh_docs/pdf11/K110560.pdf).These antibiotics were chosen as they cover the majority of Staphylococcus aureus and may provide some activity against coagulase negative staphylococci.1 These normal skin flora account for the majority of VP shunt infections.In the largest randomized controlled trial(RCT)to date,AIVSCs significantly reduced the risk of infection compared with standard shunts(cause-specific hazard ratio(HR)0.38).2 This effect was mainly due to a reduction in staphylococcal infections;the number of gram-negative infections was similar in both groups.Observational studies3–5 and a meta-analysis6 in children support the findings of this RCT.The objective of this study was to examine the spectrum of pathogens,time to infection,and outcomes with AIVSCs vs standard shunts.Joan Robinson Archana Balamohan Michelle Barton Marie-Astrid Lefebvre Ahmed Almadani Dolores Freire Alastair McAlpine Jocelyn Srigley Patrick Passarelli John Bradley Dele Davies Gwenn Skar Isabelle Viel-Theriault Sarah Khan Rupeena Purewal Nicole LeSaux Jennifer Bowes Michael Hawkes 2023World Journal of Pediatric Surgery2023,6,3:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费